KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

56 hedge funds and large institutions have $222M invested in Kindred Biosciences, Inc. in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 26 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+17
Holders Change %
+43.59%
% of All Funds
1.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
26
Reduced
3
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Barclays
51
Barclays
United Kingdom
$7K +$2.97K +173 +74%
BlackRock
52
BlackRock
New York
$5K
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$5K +$5K +260 New
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$2.09K +$2.09K +112 New
TRCT
55
Tower Research Capital (TRC)
New York
$2K -$8.04K -402 -80%
Citigroup
56
Citigroup
New York
$2K +$989 +44 +98%
TG
57
TCW Group
California
-$1.82M -98,363 Closed
SIM
58
Spark Investment Management
New York
-$339K -18,400 Closed
SCA
59
SAC Capital Advisors
Connecticut
-$293K -15,790 Closed
PAM
60
Panagora Asset Management
Massachusetts
-$244K -13,150 Closed
PP
61
PDT Partners
New York
-$217K -11,694 Closed
Citadel Advisors
62
Citadel Advisors
Florida
-$155K -8,385 Closed